SPY
778.57
+0.60%
QQQ
751.38
+0.51%
BTC/USD
82,766.04
−0.19%
DIA
516.21
+0.89%
GLD
384.50
+1.55%
TLT
77.97
+0.12%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Pulmatrix Inc
PULM
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.46
-0.0671
-4.39%
Last update: Oct 9, 4:00 PM
Get Report
Overview
News
Earnings Forecast
Financials
Sentiment
Ownership
Compare
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Pulmatrix Analyst Price Targets
Wall Street analyst price targets and consensus rating for Pulmatrix (PULM).
Analyst Ratings News
PRO
HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Pulmatrix, Raises Price Target to $10
HC Wainwright & Co. analyst Andrew Fein maintains Pulmatrix (NASDAQ:PULM) with a Buy and raises the price target from $5 to $10.
Benzinga Newsdesk
10 Biggest Price Target Changes For Tuesday
Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading.
Lisa Levin
PRO
HC Wainwright & Co. Maintains Buy on Pulmatrix, Lowers Price Target to $5
HC Wainwright & Co. analyst Andrew Fein maintains Pulmatrix (NASDAQ:PULM) with a Buy and lowers the price target from $10 to $5.
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
Eli Lilly and Co
NYSE:LLY
$1177.05
0.64%
Johnson & Johnson
NYSE:JNJ
$261
1.76%
Merck & Co Inc
NYSE:MRK
$146.31
2.76%
Novartis AG
NYSE:NVS
$143.75
0.45%
AstraZeneca PLC
NYSE:AZN
$159.2
0.26%
Novo Nordisk AS
NYSE:NVO
$38.6
1.1%
Pfizer Inc
NYSE:PFE
$28.27
1.61%
Bristol-Myers Squibb Co
NYSE:BMY
$59.14
-0.75%
Sanofi SA
NASDAQ:SNY
$40.25
0.06%
GSK PLC
NYSE:GSK
$46.5
-0.09%
Show all 10 related companies
